Li X, Xiao Z, Zhang J, Huang X, Lin H, Huang S
BMC Cardiovasc Disord. 2025; 25(1):163.
PMID: 40055600
PMC: 11887063.
DOI: 10.1186/s12872-025-04597-9.
Lengauer S, Erhard N, Popa M, Telishevska M, Krafft H, Bahlke F
J Cardiovasc Electrophysiol. 2025; 36(3):625-631.
PMID: 39853802
PMC: 11903373.
DOI: 10.1111/jce.16567.
Fusaroli M, Hoogendijk M, Bhagwandien R, Wijchers S, van Boven N, Mahmoodi B
J Interv Card Electrophysiol. 2025; .
PMID: 39797967
DOI: 10.1007/s10840-025-01982-4.
Tzeis S, Gerstenfeld E, Kalman J, Saad E, Sepehri Shamloo A, Andrade J
J Arrhythm. 2024; 40(6):1217-1354.
PMID: 39669937
PMC: 11632303.
DOI: 10.1002/joa3.13082.
Liu G, Shao B, Wu W, Zhou L, Cui J, Chen W
Front Cardiovasc Med. 2024; 11:1510889.
PMID: 39639974
PMC: 11617511.
DOI: 10.3389/fcvm.2024.1510889.
Early ablation leads to better outcome in patients < 55 years with persistent atrial fibrillation.
Erhard N, Bahlke F, Neuner B, Popa M, Krafft H, Tunsch-Martinez A
Sci Rep. 2024; 14(1):25370.
PMID: 39455654
PMC: 11511932.
DOI: 10.1038/s41598-024-76098-2.
Early rapid local impedance drop is associated with acute lesion efficacy during pulmonary vein isolation.
Perge P, Petrovic N, Sallo Z, Piros K, Nagy V, Abraham P
Europace. 2024; 26(10).
PMID: 39373571
PMC: 11493088.
DOI: 10.1093/europace/euae260.
In vitro characterization of radiofrequency ablation lesions in equine and swine myocardial tissue.
Buschmann E, Van Steenkiste G, Duytschaever M, Segers P, Ibrahim L, van Loon G
Sci Rep. 2024; 14(1):22877.
PMID: 39358479
PMC: 11447003.
DOI: 10.1038/s41598-024-74486-2.
High-Power Short-Duration Posterior Wall Isolation in Addition to Pulmonary Vein Isolation in Persistent Atrial Fibrillation Ablation Using the New TactiFlex™ Ablation Catheter.
Conti S, Sabatino F, Randazzo G, Ferrara G, Cascino A, Sgarito G
J Cardiovasc Dev Dis. 2024; 11(9).
PMID: 39330352
PMC: 11432285.
DOI: 10.3390/jcdd11090294.
Radiofrequency Lesion in the Atrial Wall: How Variable Is It? 9.4 Tesla MRI Analysis of Radiofrequency Lesion Volume in a Swine Model.
Cardelli L, Laumont T, Beghian J, Achahli Y, Cardoso M, Bacle M
J Clin Med. 2024; 13(17).
PMID: 39274366
PMC: 11396762.
DOI: 10.3390/jcm13175153.
The effect of different power radiofrequency ablations in treatment and postoperative pain in patients with atrial fibrillation: a retrospective study.
Chen Y, Jin J, Zhu L, Zhang Y, Wei C, Yang Q
BMC Cardiovasc Disord. 2024; 24(1):478.
PMID: 39251900
PMC: 11382463.
DOI: 10.1186/s12872-024-04147-9.
Comparative Analysis of Clinical Outcomes of High-power, Short-duration Ablation versus Low-power, Long-duration Ablation Strategy in Patients with Atrial Fibrillation: A Comprehensive Umbrella Review of Meta-analyses.
Pavani P, Olanrewaju O, Sagar R, Bai M, Chand J, Bhatia V
J Innov Card Rhythm Manag. 2024; 15(8):5963-5980.
PMID: 39193534
PMC: 11346500.
DOI: 10.19102/icrm.2024.15083.
Catheter Ablation of Persistent AF-Where are We Now?.
ONeill L, De Becker B, De Smet M, Francois C, Le Polain De Waroux J, Tavernier R
Rev Cardiovasc Med. 2024; 24(12):339.
PMID: 39077091
PMC: 11262453.
DOI: 10.31083/j.rcm2412339.
Next-generation atrial fibrillation ablation: clinical performance of pulsed-field ablation and very high-power short-duration radiofrequency.
Soubh N, Gronwald J, Haarmann H, Rasenack E, Bengel P, Schlogl S
J Interv Card Electrophysiol. 2024; 67(9):2067-2075.
PMID: 38997610
PMC: 11711250.
DOI: 10.1007/s10840-024-01853-4.
Long-term outcome of high-power ablation guided by ablation index in the treatment of atrial fibrillation.
Mao S, Wang L, Fan H, Yang L, Wang X, Liang B
J Arrhythm. 2024; 40(3):455-462.
PMID: 38939788
PMC: 11199812.
DOI: 10.1002/joa3.13035.
Difference in radiofrequency ablation profile between during sinus rhythm and atrial fibrillation: Considerations in this era of high-power short-duration strategy.
Hara S, Kusa S, Sato Y, Ohya H, Miwa N, Hirano H
J Arrhythm. 2024; 40(3):448-454.
PMID: 38939764
PMC: 11199806.
DOI: 10.1002/joa3.13025.
Pulmonary Vein Isolation for Atrial Fibrillation: Comparison of a Very High-Power Very Short-Duration (vHPvSD) Ablation Protocol versus a Hybrid Ablation Approach-Procedural and Mid-Term Outcome Data.
Baumgartner A, Martinek M, Derndorfer M, Kollias G, Ammann P, Purerfellner H
J Clin Med. 2024; 13(10).
PMID: 38792421
PMC: 11121963.
DOI: 10.3390/jcm13102879.
Initial experience, safety, and feasibility using remote access or onsite technical support for complex ablation procedures: results of the REMOTE study.
Heeger C, Vogler J, Eitel C, Feher M, Popescu S, Kirstein B
Eur Heart J Digit Health. 2024; 5(3):356-362.
PMID: 38774365
PMC: 11104456.
DOI: 10.1093/ehjdh/ztae013.
Personalized pulmonary vein isolation with very high-power short-duration lesions guided by left atrial wall thickness: the QDOT-by-LAWT randomized trial.
Falasconi G, Penela D, Soto-Iglesias D, Francia P, Saglietto A, Turturiello D
Europace. 2024; 26(4).
PMID: 38652090
PMC: 11036893.
DOI: 10.1093/europace/euae087.
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.
Tzeis S, Gerstenfeld E, Kalman J, Saad E, Sepehri Shamloo A, Andrade J
J Interv Card Electrophysiol. 2024; 67(5):921-1072.
PMID: 38609733
DOI: 10.1007/s10840-024-01771-5.